Korean Market
OWNR
Hana Pharm
★

Executive Jo Ye-rim Increases Stake in Hana Pharm to 11.75% via Open Market Purchases, Signaling Management Confidence

 
EXCH
Hana Pharm
★

Hana Pharm Major Shareholder Stake Rises to 58.70% from 57.71% via Open Market Purchases by Family Members

 
OWNR
Hana Pharm
★

Hana Pharm Vice President Jo Hye-rim Increases Stake to 11.70% via Open Market Purchases, Signaling Management Commitment

 
EXCH
Hana Pharm
★

Hana Pharm: 2025 Net Profit Plunges and Dividend Cut, Multiple Governance Non-Compliances Exposed

 
PERI
Hana Pharm
★★★

Hana Pharm Q1 2026: Revenue 62.2B, Operating Profit 7.1B – Strong Results

 
EXCH
Hana Pharm
★★

2025 Preliminary Earnings: Net Profit Plunges 58.5% Due to Tax Investigation Losses